MedPath

Diabetes and Ayurved

Completed
Conditions
PRAMEHI
Registration Number
CTRI/2018/04/013525
Lead Sponsor
GOVERMENT AKANDANAND AYURVED COLLEGE AHMEDABAD
Brief Summary

This study is rendomised, participiant,blinded,parellel group,active controlled trial to compare the efficasy of chitarakadikwath 40 ml bd with or  without vaman karma with the dutation of 6weeks after vaman karma in 30 patienis of sthool prameha.Which will be conducted in india.

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
30
Inclusion Criteria
  • Patient having classical signs and symptoms of the disease according to Ayurveda well as Modern science. 1 Patients of Prameha having BMI 25 to 35 2 Patient of NIDDM with blood sugar level more then.
  • F.B.S.- 126 mg/dl or P.P.B.S.-180 mg/dl. 3 Age group of 16-60 years. 4 Disease chronicity 10 year. 5 Patient otherwise healthy and fit for Shodhana(Vamana) and Chirakadikwath as per the Ayurvedic text.
Exclusion Criteria
  • Patients of Prameha having BMI < 25 &>35 1 Patients of Type-1 Diabetes or the patients of Type-2 Diabetes taking Insulin.
  • 2 Patients having complications of Diabetes like Nephropathy, Retinopathy, Diabetic Foot,Carbuncles etc.
  • 3 Age <16 to > 60 years.
  • 4 Patients having Diabetes in association with other endocrinopathies like Pheochromocytoma, Acromegaly, Cushing’s syndrome, Hyperthyroidism etc.
  • 5 Patients having drug or chemical induced Type-II Diabetes, like glucocorticoids induced or thyroid hormone induced etc.
  • 6 Patients with genetic syndromes associated with Type-II Diabetes like Down’s syndrome, Klinefelter’s Syndrome, and Turner’s syndrome etc.
  • 7 Patients complicated with any cardiovascular diseases, renal diseases, Carcinoma or any other disease effecting multiple body systems and pregnant women etc.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
All the signs and symptoms of Pramehi will be assigned score depending upone their severity to assess the effect of the drugsat the time of before treatment and after treatment.After 3 months
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

GOVT AKHANDANAND AYURVED COLLEGE AND HOSPITAL AHMEDABAD AND MANIBEN AYURVED HOSPITAL AHMEDABAD

🇮🇳

Ahmadabad, GUJARAT, India

GOVT AKHANDANAND AYURVED COLLEGE AND HOSPITAL AHMEDABAD AND MANIBEN AYURVED HOSPITAL AHMEDABAD
🇮🇳Ahmadabad, GUJARAT, India
NIHARIKA JITENDRAKUMAR PRAJAPATI
Principal investigator
7778994755
drniharikaprajapati15@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.